Form 4: Relay Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Donald A. Bergstrom, President of R&D at Relay Therapeutics, sold shares to cover income tax withholding obligations upon the vesting of restricted stock units.
Summary
- On October 28, 2024, Donald A. Bergstrom, President of R&D at Relay Therapeutics, sold 2,688 shares of common stock at a price of $6.06 per share.
- The sale was executed to cover income tax withholding obligations related to the vesting of 9,072 restricted stock units (RSUs) on October 27, 2024.
- Following the transaction, Bergstrom beneficially owns 520,745 shares of Relay Therapeutics, which includes 449,977 shares underlying RSUs.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an executive's stock sale to cover tax obligations. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors.
Key Dates
| Date | Description |
|---|---|
| 10/27/2024 | Vesting of 9,072 shares of restricted stock units (RSUs). |
| 10/28/2024 | Sale of 2,688 shares of common stock by Donald A. Bergstrom. |
| 10/30/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.